Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study

CONCLUSION: Despite some limitations due to study design and study-roll out, CEM studies can allow prompt and almost real-time observations of the safety of medications directly from a patient-centered perspective, which can play a crucial role for regulatory bodies during an emergency setting such as the COVID-19 pandemic.PMID:38448322 | DOI:10.1016/j.vaccine.2024.03.001

Source: Vaccine - March 6, 2024 Category: Allergy & Immunology Authors: Monika Raethke Florence van Hunsel Nicoletta Luxi Thomas Lieber Chiara Bellitto Erik Mulder Francesco Ciccimarra Fabio Riefolo Nicolas H Thurin Debabrata Roy Kathryn Morton Felipe Villalobos Francisco Batel Marques Andreea Farcas Simona Sonderlichov á Sv Source Type: research